AGENTS STRENGTHENING THE ACTION OF AMPA RECEPTORS

摘要

The present invention relates to a compound according to Formula I, or a pharmaceutically acceptable salt of said compound, which can be used to treat conditions associated with decreased glutamate function, for example, psychiatric and neurological disorders.